| Bioactivity | PD 130908 is an orally active hypoxic cell radiosensitizer with potent radiosensitizing activity. PD 130908 can be utilized in cancer research[1]. |
| CAS | 131505-02-7 |
| Formula | C8H14Br2N4O2 |
| Molar Mass | 358.03 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Cole S, et al. Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908. Int J Radiat Oncol Biol Phys. 1992;22(3):545-8. |
PD 130908
CAS: 131505-02-7 F: C8H14Br2N4O2 W: 358.03
PD 130908 is an orally active hypoxic cell radiosensitizer with potent radiosensitizing activity. PD 130908 can be utili
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.